Peng D, Li X S, Zhang C J, Yang K W, Tang Q, Zhang L, Yu X T, He Z S, Zhou L Q
Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center; Beijing 100034, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Oct 18;48(5):806-811.
To evaluate the impacts of clinical, pathological, and laboratory factors on oncological outcomes of patients with T3N0M0 renal cell carcinoma.
The clinical data, laboratory exam results, and follow-up outcomes of 182 patients with T3N0M0 renal cell carcinoma who underwent nephrectomy from 2007 to 2012 in Peking University First Hospital were retrospectively collected. The 5-year cancer-specific survival and 5-year recurrence-free survival of all the patients were calculated using Kaplan-Meier method, and the statistical significance between the survival curves were compared using the Log-rank test. Variables with significant differences in the univariate analysis were subjected to the multivariate analysis by Cox regression model. All the comparisons were conducted using two-tailed test and P<0.05 was considered statistically significant.
A total of 182 patients were included in this study. Of all the 182 patients, 126 were male (69.23%) and 56 were female (30.77%). The mean age was (56.75±12.45) years. The median follow-up time was 48 months (3-99 months). At the end of the follow-up, 50 patients (27.47%) died due to the disease after a median of 29.74 months and 59 patients (32.42%) had tumor recurrence after a median of 22.12 months. The 5-year cancer-specific survival of all patients was 68.30% (95% CI: 60.16%-75.84%); the 5-year recurrence-free survival was 60.70% (95% CI: 53.16%-68.84%). In the univariate analysis, diabetes mellitus, tumor invasion status, Fuhrman grade, serum album, serum cholestenone, anemia, and neutrophils percentage were associated with the cancer-specific survival and Fuhrman grade, serum album and anemia were associated with the recurrence-free survival. Variables with significant differences on univariate analysis were included in Cox multivariate regression analysis. Multivariate Logistic regression analysis showed that diabetes mellitus (HR=2.434, 95% CI: 1.243-4.769, P=0.010), hypoalbuminemia (HR=2.188, 95% CI: 1.074-1.074, P=0.031), and anemia (HR=3.320, 95% CI: 1.839-5.991, P<0.001) were independent risk factors significantly associated with cancer-specific survival; and higher Fuhrman grade (HR=2.552, 95% CI: 1.433-4.545, P=0.001), anemia (HR=2.535, 95% CI: 1.497-4.293, P=0.001) were independent factors significantly associated with recurrence-free survival.
Diabetes mellitus, hypoalbuminemia, and anemia were independent risk factors significantly associated with cancer-specific survival of T3N0M0 renal cell carcinoma patients; higher Fuhrman grade and anemia were independent risk factors significantly associated with tumor recurrence of T3N0M0 renal cell carcinoma patients.
评估临床、病理及实验室因素对T3N0M0期肾细胞癌患者肿瘤学结局的影响。
回顾性收集2007年至2012年在北京大学第一医院接受肾切除术的182例T3N0M0期肾细胞癌患者的临床资料、实验室检查结果及随访结局。采用Kaplan-Meier法计算所有患者的5年癌症特异性生存率和5年无复发生存率,并使用Log-rank检验比较生存曲线之间的统计学显著性。单因素分析中有显著差异的变量通过Cox回归模型进行多因素分析。所有比较均采用双侧检验,P<0.05被认为具有统计学显著性。
本研究共纳入182例患者。在这182例患者中,男性126例(69.23%),女性56例(30.77%)。平均年龄为(56.75±12.45)岁。中位随访时间为48个月(3 - 99个月)。随访结束时,50例患者(27.47%)在中位29.74个月后因疾病死亡,59例患者(32.42%)在中位22.12个月后出现肿瘤复发。所有患者的5年癌症特异性生存率为68.30%(95%CI:60.16% - 75.84%);5年无复发生存率为60.70%(95%CI:53.16% - 68.84%)。单因素分析中,糖尿病、肿瘤侵犯状态、Fuhrman分级、血清白蛋白、血清胆固醇、贫血及中性粒细胞百分比与癌症特异性生存率相关,Fuhrman分级、血清白蛋白及贫血与无复发生存率相关。单因素分析中有显著差异的变量纳入Cox多因素回归分析。多因素Logistic回归分析显示,糖尿病(HR = 2.434,95%CI:1.243 - 4.769,P = 0.010)、低白蛋白血症(HR = 2.188,95%CI:1.074 - 1.074,P = 0.031)及贫血(HR = 3.320,95%CI:1.839 - 5.991,P<0.001)是与癌症特异性生存率显著相关的独立危险因素;较高的Fuhrman分级(HR = 2.552,95%CI:1.433 - 4.545,P = 0.001)、贫血(HR = 2.535,95%CI:1.497 - 4.293,P = 0.001)是与无复发生存率显著相关的独立因素。
糖尿病、低白蛋白血症及贫血是与T3N0M0期肾细胞癌患者癌症特异性生存率显著相关的独立危险因素;较高的Fuhrman分级及贫血是与T3N0M0期肾细胞癌患者肿瘤复发显著相关的独立危险因素。